Vorinostat
Prescription anticancer drug approved for a skin lymphoma; its nerve-protecting effect has only been seen in animal studies.
Pharmacology
Contents
DETAILED OVERVIEW
What is Vorinostat?
Vorinostat (SAHA) is a prescription anticancer drug that was approved in the United States in 2006 under the name Zolinza for a certain skin lymphoma (cutaneous T-cell lymphoma); it is not approved in the European Union. It is not a dietary supplement and not a nootropic: its use for memory or nerve protection is purely experimental and possible only under medical supervision.
It blocks enzymes that control how readable genes are; in tumor cells this stops cell division and triggers programmed cell death. In rodents the same effect reversed learning and memory problems caused by stress or anesthesia, but in humans a nerve-protecting benefit has never been shown, and it enters the brain poorly. As a cancer drug it has serious side effects, for example nausea, diarrhea, a drop in platelets and blood cells, blood clots (for example pulmonary embolism) and a disturbance of the heart's electrical activity (QT prolongation). It must not be used in pregnancy because it can harm the fetus.
Mechanism
Broad histone deacetylase inhibitor; binds the enzyme's zinc
Half-life
Approximately 2 hours
Legal status
FDA-approved prescription cancer drug
No anecdote collected yet.
Receptor profile
- Histone deacetylase (HDAC) enzymesStrong
- Gene transcription / chromatin remodelingStrong
- Memory and neuroprotection (research)Weak
Safety
Side effects, stop signs, contraindications
Side effects · 6
- Fatigue, nausea, diarrhea (common at clinical oncology doses)
- Reduced platelet and blood cell counts (thrombocytopenia, anemia)
- Increased tendency to blood clots (risk of pulmonary embolism and deep vein thrombosis)
- Fluctuating blood glucose (hyperglycemia)
- Prolongation of cardiac electrical conduction (QT prolongation)
- Dehydration, loss of appetite, taste disturbance
Contraindications · 5
- Pregnancy and breastfeeding: teratogenic and fetotoxic, strictly avoid
- History of thromboembolism (deep vein thrombosis, pulmonary embolism): increased clot risk
- QT prolongation or concurrent QT-prolonging drugs: arrhythmia risk
- Bone marrow suppression or low platelet count: requires regular blood-count monitoring
- Prescription oncology drug, only under medical supervision; not for self-medication
Related Nootropics
Same therapeutic category
Studies
Related research and clinical findings
Suberoylanilide Hydroxamic Acid (SAHA) Is a Driver Molecule of Neuroplasticity: Implication for Neurological Diseases
Epigenetic modifications by inhibiting histone deacetylases reverse memory impairment in insulin resistance induced cognitive deficit in mice
Suberoylanilide hydroxamic acid reversed cognitive and synaptic plasticity impairments induced by sevoflurane exposure in adult mice
Cognitive Improvement by Vorinostat through Modulation of Endoplasmic Reticulum Stress in a Corticosterone-Induced Chronic Stress Model in Mice
Repurposing Vorinostat for the Treatment of Disorders Affecting Brain
SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition
FAQ
FAQ
Vorinostat is an FDA-approved cancer drug (used for a specific type of skin lymphoma), and its brain-protective, memory-boosting effect has so far only been observed in animal studies. In rodent models it improved learning and memory problems caused by stress, insulin resistance, or anesthesia by changing how certain genes are read out, but using it for cognitive purposes in humans is not an approved use, it remains purely research/experimental at this stage.
Telegram
Have a question about Vorinostat?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.